A new peer reviewed publication related to mitochondrial derived peptides was released on October 1, 2026. The paper, titled "Mitochondrial Peptide SHLP2 Limits Poly(I:C)-Induced Alveolar Epithelial Injury by Modulating Redox, Apoptotic, Inflammatory, and Inflammasome Responses," appears in the journal Cytotechnology. The publication is indexed under PubMed ID 42774487. This entry reports the existence and title of the study only, as listed in the source record. Humanin belongs to the broader family of mitochondrial derived peptides that includes SHLP2, and research on related peptides in this family is sometimes reported alongside humanin studies. No specific findings, data, or conclusions from the paper are described here beyond its title and journal placement. Humanin remains classified as unapproved and is used only in a research context. Readers interested in the details of the study's methods or reported outcomes should consult the original publication directly through the provided source link. For general background on humanin, including its classification and research status, see the compound overview.
SHLP2 Study Published in Cytotechnology on Alveolar Injury Model
Source: https://pubmed.ncbi.nlm.nih.gov/42774487/